ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
17.00033
0.33%
Brent Oil
83.565
0.03%
Bitcoin
59,252.41
1.74%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. LivaNova PLC (LIVN)

  7. LivaNova PLC (LIVN) Noticias

LIVN LivaNova PLC

62.92
0.30 (0.48%)
Fuera de horario
Última actualización: 15:03:35
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
LivaNova PLC LIVN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.30 0.48% 62.92 15:03:35
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
62.63 60.07 62.94 62.92 62.62
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202405:00BWLivaNova Reports First-Quarter 2024 Results
30/4/202408:00BWLivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation..
25/4/202415:03BWLivaNova Issues Notice to U.S. Patients Regarding..
21/3/202408:00BWLivaNova to Announce First-Quarter 2024 Results
20/3/202408:00BWLivaNova Announces a Positive Predictive Outcome of Trial..
11/3/202415:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202420:55EDGAR2Form 8-K - Current report
05/3/202420:55BWLivaNova Announces Pricing of Private Offering of $300..
04/3/202416:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/3/202416:22EDGAR2Form 8-K - Current report
04/3/202415:44BWLivaNova Announces Proposed Private Offering of $300 Million..
04/3/202408:00BWLivaNova to Present at the Barclays Global Healthcare..
29/2/202412:26EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
29/2/202412:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202405:03EDGAR2Form 8-K - Current report
21/2/202405:00BWLivaNova Reports Fourth-Quarter and Full-Year 2023 Results
05/2/202407:11EDGAR2Form 8-K - Current report
05/2/202407:00BWLivaNova Announces Vladimir A. Makatsaria as CEO and Board..
08/1/202407:32EDGAR2Form 8-K - Current report
08/1/202407:30BWLivaNova to Wind Down Advanced Circulatory Support Business..
04/1/202408:00BWLivaNova to Announce Fourth-Quarter and Full-Year 2023..
19/12/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:30EDGAR2Form 8-K - Current report
06/12/202306:00EDGAR2Form 8-K - Current report
20/11/202316:15EDGAR2Form 8-K - Current report
09/11/202308:00BWLivaNova to Present at the Piper Sandler Healthcare..
01/11/202314:03EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
01/11/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202305:05EDGAR2Form 8-K - Current report
01/11/202305:00BWLivaNova Reports Third-Quarter 2023 Results
25/10/202308:00BWLivaNova to Present at the Stifel and Wolfe Healthcare..
19/10/202315:09EDGAR2Form 8-K - Current report
13/10/202315:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/10/202307:41EDGAR2Form 8-K - Current report
06/10/202307:30BWLivaNova Board Appoints J. Christopher Barry as New Director
21/9/202315:20EDGAR2Form 8-K/A - Current report: [Amend]
21/9/202306:09EDGAR2Form 8-K - Current report
21/9/202306:00BWLivaNova Announces Marco Dolci, President of..
20/9/202308:00BWLivaNova to Announce Third-Quarter 2023 Results
19/9/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202317:57BWLivaNova präsentiert Essenz In-Line Blood Monitor mit U.S...
30/8/202317:39BWLivaNova dévoile son moniteur de sang en ligne Essenz, qui..
30/8/202315:05BWLivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA..
24/8/202308:00BWLivaNova to Present at the Baird Global Healthcare..
26/7/202314:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/7/202314:24EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
26/7/202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/7/202305:05EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
LIVN
LivaNova
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados